Log In
Print
BCIQ
Print
Print this Print this
 

LPCN 1111

  Manage Alerts
Collapse Summary General Information
Company Lipocine Inc.
DescriptionOnce-daily oral formulation of testosterone using Lipocine's Lip'ral oral delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypogonadism
Indication DetailsTreat hypogonadism
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today